Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Michael O'Riordan

April 12, 2021

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

Michael O'Riordan

March 08, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

Caitlin E. Cox

October 31, 2018

News Daily News

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Michael O'Riordan

October 15, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

News Daily News

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Shelley Wood

January 17, 2018

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

CANTOS: Canakinumab Cuts MI, Stroke in Post-MI Patients With Elevated CRP

News Daily News

CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP

Todd Neale

June 22, 2017

News Daily News

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Todd Neale

May 27, 2016

Advertisement

ACC: It’s Time for Clinicians to Address Inflammation in CVD

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Recurrent Events Common Among Young Patients With CAD

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Rising Inflammatory Tides: Increasing CRP Levels After ACS Tied to Greater CVD Risks

TCTMD’s Top 10 Most Popular Stories for February 2019

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

TCTMD’s Top 10 Most Popular Stories for June 2017

CANTOS: Canakinumab Cuts Combo of MI, Stroke, CV Death in Post-MI Patients With Elevated CRP

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content